Post-effective amendment to a registration statement that is not immediately effective upon filing

CONSOLIDATED BALANCE SHEETS

v3.22.1
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Dec. 31, 2021
Dec. 31, 2020
Current assets:    
Cash $ 27,605 $ 1,859
Account receivable, net of allowance of $257 as of December 31, 2020   831
Prepaid expenses and other current assets 5,109 240
Total current assets 32,714 2,930
Other assets 15 11
Total assets 32,729 2,941
Current liabilities:    
Accounts payable 3,687 3,153
Accrued and other current liabilities 2,375 1,729
Accrued clinical site costs 469 1,547
Earnout Cash liability 4,582  
Warrant liabilities 292  
Notes payable and accrued interest 518 249
Accrued settlement expense   39,486
Total current liabilities 11,923 46,164
Notes payable and accrued interest   548
Total liabilities 11,923 46,712
Stockholders' equity (deficit):    
Preferred stock, $0.001 par value, 50,000,000 shares authorized; 0 shares issued and outstanding at December 31, 2021 and 2020, respectively
Common stock, $0.001 par value, 500,000,000 shares authorized; 58,810,550 and 42,973,462 shares issued and outstanding at December 31, 2021 and 2020, respectively 59 43
Additional paid-in capital 203,990 46,366
Accumulated deficit (183,243) (90,180)
Total stockholders' equity (deficit) 20,806 (43,771)
Total liabilities and stockholders' equity (deficit) $ 32,729 $ 2,941